A prostate cancer imaging breakthrough could cut waiting times after “extremely encouraging” results in its first clinical trials.
The new approach, which uses existing ultrasound technology, demonstrated an initial 94% sensitivity rate in tumour detection, and the test is delivered in under 20 minutes.
